Abstract: The invention provides polypeptides, designated herein as POLYX polypeptides, as well as polynucleotides encoding POLYX polypeptides, and antibodies that immunospecifically-bind to POLYX polypeptide or polynucleotide, or derivatives, variants, mutants, or fragments thereof. The invention additionally provides methods in which the POLYX polypeptide, polynucleotide, and antibody are used in the detection, prevention, and treatment of a broad range of pathological states.

Abstract: This application is drawn to novel nucleic acid sequences encoding mammalian polypeptides that have sequence similarity to human fibroblast growth factor, FGF-10. The nucleic acid sequence is 670 nucleotides long and contains an open reading frame from nucleotides 130 to 639. The encoded polypeptides are novel secreted proteins.

Abstract: The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.

Abstract: This application is drawn to novel amino acid sequences for mammalian polypeptides that have sequence similarity to the fragment F40E10.6 from Caenorhabditis elegans. The polypeptides are novel proteins of approximately 260 amino acids.

Abstract: This application is drawn to novel nucleic acid sequences encoding mammalian polypeptides that have sequence similarity to human vesicle transport protein and residue rat protein, ACC:Q62825. The nucleic acid sequence is 1265 nucleotides long and contains an open reading frame from nucleotides 142 to 1236. The encoded polypeptides are novel proteins of 365 residues.

Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further disclosed therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: This application is drawn to novel nucleic acid sequences encoding mammalian polypeptides that have sequence similarity to a human cell adhesion molecule protein. The nucleic acid sequence is 2116 nucleotides long and contains an open reading frame from nucleotides 517-19 to 1729-31. The novel, encoded polypeptides comprise 404 amino acid residues.

Abstract: The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.

Abstract: This application is drawn to novel amino acid sequences for mammalian polypeptides that have sequence similarity to precursors of human kidney cadherin-6 and cadherin-10 from Gallus gallus. The novel polypeptides comprise about 473 amino acids.

Abstract: This application is drawn to novel nucleic acid sequences encoding mammalian polypeptides that have sequence similarity to human and Mus musculus Semaphorin. The nucleic acid sequence is 2284 nucleotides long and contains an open reading frame from nucleotides 166 to 1956. The encoded novel polypeptides comprise about 596 amino acids.

Abstract: This application is drawn to novel nucleic acid sequences encoding mammalian polypeptides that have sequence similarity to human breast tumor-associated protein 47. The nucleic acid sequence is 1987 nucleotides long and contains an open reading frame from nucleotides 991 to 1447. The novel, encoded polypeptides comprise 152 amino acid residues.

Abstract: The present invention provides novel isolated SECX polynucleotides and the membrane-associated or secreted polypeptides encoded by the SECX polynucleotides. Also provided are the antibodies that immunospecifically bind to a SECX polypeptide or any derivative, variant, mutant or fragment of the SECX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the SECX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.

Abstract: This application is drawn to novel amino acid sequences for mammalian polypeptides that have sequence similarity to fetal brain tissue protein. The polypeptides are novel secreted proteins 649 amino acids in length.

Abstract: This application is drawn to novel amino acid sequences for mammalian polypeptides that have sequence similarity to human cell adhesion molecule KIAA1061, and processes for preparing the same.

Abstract: This application is drawn to novel amino acid sequences for mammalian polypeptides that have sequence similarity to human microfibril-associated glycoprotein 4, and processes for preparing the same. The clone identified has a nucleic acid sequence that is 1099 nucleotides long, contains an open reading frame from nucleotides 83-85 to 890-892, and encodes a novel polypeptide that is 269 amino acids long.

Abstract: This application is drawn to novel nucleic acid sequences encoding mammalian polypeptides that have sequence similarity to human angiopoietin-related proteins. The nucleic acid sequence is 1855 nucleotides long and contains an open reading frame from nucleotides 154-6 to 1369-71. The encoded polypeptides are about 405 amino acid residues in length.

Abstract: This application is drawn to novel amino acid sequences for mammalian polypeptides that have sequence similarity of human and mus musculus Semaphorin. The encoded novel polypeptides comprise about 590 amino acids.

Abstract: The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.